Bridgebio Oncology Therapeutics Inc share price logo

Bridgebio Oncology Therapeutics Inc Share Price

NASDAQ: BBOT

Small Cap

$12.30

-0.10

(-0.81%)

Live

as on

Bridgebio Oncology Therapeutics Inc Stock Performance

as on November 7, 2025 at 12:37 am IST

  • Day's Low

    Day's High

    $12.13
    $12.62
    downward going graph

    1.38%

    Downside

    2.60%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $8.7
    $13.18
    downward going graph

    29.27%

    Downside

    7.15%

    Upside

    downward going graph

Bridgebio Oncology Therapeutics Inc share price movements today

Previous Close
$12.40
Open
$12.31
Volume
103.4K
Day's Low - High
$12.13 - $12.62
52 Week Low - High
$8.7 - $13.18

Bridgebio Oncology Therapeutics Inc Historical Returns

1 Month Return
-1.04 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Bridgebio Oncology Therapeutics Inc Stock Fundamentals & Key Indicators

Check Bridgebio Oncology Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Bridgebio Oncology Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bridgebio Oncology Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Bridgebio Oncology Therapeutics Inc image
Bridgebio Oncology Therapeutics Inc
NA$-NANA0.00%
Insmed Incorporated image
Insmed Incorporated
BUY$39.9B473.78%-16.34-264.83%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$55.9B232.41%1411.571.36%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$108.1B89.3%29.6331.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$67.5B11.45%15.3832.13%

Bridgebio Oncology Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Bridgebio Oncology Therapeutics Inc Stock has increased by 167% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:167% versus previous 30 day period

Bridgebio Oncology Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Income
0
0
-2
-1
EBITDA
0
0
-2
-1
Interest Expense
-
-
-
-
Depreciation
0
0
0
0
Income Before Tax
1
2
0
0
Income Tax Expense
-
-
-
-
Net Income
1
2
0
0
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Bridgebio Oncology Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2023
Dec 2024
Total Revenue
-
-
Gross Profit
-
-
Operating Income
0
0
EBITDA
0
7
Interest Expense
-
-
Depreciation
0
0
Income Before Tax
0
7
Income Tax Expense
-
-
Net Income
0
7
Net Profit Margin
0.00%
0.00%

Bridgebio Oncology Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
0
1
2
2
1
0
0
Operating Cash Flow
-
0
0
0
0
0
0
Investing Cash Flow
-
-184
-
184
-
-
-
Financing Cash Flow
-
186
199
-
-
0
18
Change in Cash
-
1
0
0
0
0
0

Bridgebio Oncology Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Net Income
0
0
7
Operating Cash Flow
-
-52
0
Investing Cash Flow
-
-
-184
Financing Cash Flow
-
55
186
Change in Cash
-
0
1

Insights on Bridgebio Oncology Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, BBOT stock has moved up by 3.3%

About Bridgebio Oncology Therapeutics Inc

Bridgebio Oncology Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on advancing the pipeline of novel small molecule therapeutics targeting RAS and PI3Ka malignancies. Its pipeline of RAS-targeted oncology drug candidates includes BBO-8520, BBO-10203, and BBO-11818. BBO-8520 (NCT06343402) is a direct inhibitor of KRASG12C in both the ON and OFF states that is being evaluated both as monotherapy and in combination with pembrolizumab in the Phase 1 ONKORAS-101 trial for patients with KRASG12C mutant non-small cell lung cancer. BBO-10203 (NCT06625775) is an orally bioavailable small molecule that selectively and specifically blocks the physical interaction between RAS and PI3Ka, resulting in the inhibition of RAS-driven PI3Ka-AKT signaling in tumors without the risk of hyperglycemia. BBO-11818 (NCT06917079) is a panKRAS inhibitor targeting mutant KRAS in both the ON and OFF states with strong potency against KRASG12D and KRASG12V mutants.
OrganisationBridgebio Oncology Therapeutics Inc
Headquarters256 E. Grand Avenue, South San Francisco, CA, United States, 94080
CEOMr. Eli M. Wallace Ph.D.
E-voting on sharesClick here to vote

Key Management of Bridgebio Oncology Therapeutics Inc

Name

Title

Dr. Pedro J. Beltran M.D., Ph.D.

Chief Scientific Officer

Dr. Yong Ben M.B.A., M.D.

Chief Medical & Development Officer

Mr. Uneek Mehra M.B.A.

Chief Financial Officer

Mr. Howard Y. Chang M.D., Ph.D.

Vice President of Operations

Mr. Aaron Chan J.D.

Vice President of Legal

Mr. Bin Wang Ph.D.

Senior Vice President of Drug Discovery

Mr. Keshi Wang Ph.D.

Senior Vice President of DMPK & Clinical Pharmacology

Mr. Eli M. Wallace Ph.D.

CEO & Director

Mr. Idan Elmelech M.A., M.B.A.

Senior VP of Strategy & Business Development

Ms. Angela Peters

Senior Vice President of People

FAQs

What is Bridgebio Oncology Therapeutics Inc share price today?

Bridgebio Oncology Therapeutics Inc share price today is $12.3 as on . Bridgebio Oncology Therapeutics Inc share today touched a day high of $12.62 and a low of $12.13.

What is the 52 week high and 52 week low for Bridgebio Oncology Therapeutics Inc share?

Bridgebio Oncology Therapeutics Inc share touched a 52 week high of $13.18 on and a 52 week low of $8.7 on . Bridgebio Oncology Therapeutics Inc stock price today i.e. is trending at $12.3,which is 6.68% down from its 52 week high and 41.38% up from its 52 week low.

How to invest in Bridgebio Oncology Therapeutics Inc Stock (BBOT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bridgebio Oncology Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bridgebio Oncology Therapeutics Inc Shares that will get you 0.1220 shares as per Bridgebio Oncology Therapeutics Inc share price of $12.3 per share as on November 7, 2025 at 12:37 am IST.

What is the minimum amount required to buy Bridgebio Oncology Therapeutics Inc Stock (BBOT) from India?

Indian investors can start investing in Bridgebio Oncology Therapeutics Inc (BBOT) shares with as little as ₹88.566 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹885.66 in Bridgebio Oncology Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Bridgebio Oncology Therapeutics Inc share’s latest price of $12.3 as on November 7, 2025 at 12:37 am IST, you will get 0.8130 shares of Bridgebio Oncology Therapeutics Inc. Learn more about fractional shares .